MAY 2011 - NEW TITLE

© 2010-1998 American Society for Microbiology Press
Author/Editor: W. Michael Scheld
Despite progress in the prevention and control of infectious diseases during the past several decades, the early years of the 21st century provide continued evidence of the persistence and tenacity of infectious disease threats. The interplay of rapid globalization, demographic shifts, ecologic changes, and unprecedented movement of people and goods, while offering increased benefits in many arenas, also yields unexpected risks to health—often with attendant social and economic repercussions. The emergence and rapid global spread of severe acute respiratory syndrome (SARS), the widespread geographic diffusion of West Nile virus since its introduction into the Western Hemisphere and of chikungunya virus from East Africa to islands in the Indian Ocean to India and then to Italy, and the H1N1 influenza pandemic provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and challenge the global community.
Since 1995, the program committees of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Diseases Society of America (IDSA) have organized sessions on new and emerging pathogens during ICAAC and the IDSA annual meetings. These sessions are designed to address the spectrum of new and emerging bacteria, viruses, fungi, and parasites of recognized or potential scientific and public health importance, with discussions of strategies for their prevention and control.
The Emerging Infections series from ASM Press is based on these sessions.
Emerging Infections series from ASM Press is based on these sessions.
- Emerging Infections 9 (2010)
- Emerging Infections 8 (2008)
- Emerging Infections 7 (2007)
- Emerging Infections 6 (2004)
- Emerging Infections 5 (2001)
- Emerging Infections 4 (2000)
- Emerging Infections 3 (1999)
- Emerging Infections 2 (1998)
- Emerging Infections 1 (1998)
March & April 2011, SUPPLEMENTAL UPDATE

© 2011 American Pharmacists Association
Author: L. Michael Posey
APhA DrugInfoLine® is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep frontline pharmacists current on the latest trends in the biomedical literature.
May 2011, SUPPLEMENTAL UPDATE

The Review of Natural Products
© 2010 Wolters Kluwer
Authors: Ara DerMarderosian, PhD & John A. Beutler, PhD
The Review of Natural Products includes more than 300 monographs and is updated monthly. Each monograph features scientific names, common names, botan or source, history, chemistry, uses and pharmacology, dosing, pregnancy/lactation, interactions, adverse reactions, toxicology, and references.







